Introduction to the Face-Off and Metastatic TNBC Treatment Landscape

In this introductory segment, Dr. William J. Gradishar of Northwestern University Feinberg School of Medicine welcomes viewers to Cancer Network’s Face-Off and introduces the evolving treatment landscape in metastatic triple-negative breast cancer (TNBC). He outlines the program’s interactive format, in which Team Avengers and Team Guardians present differing interpretations of emerging clinical evidence and challenge one another’s perspectives. Dr. Gradishar emphasizes that the discussion is intended to be fair, balanced, and evidence-based, with the goal of evaluating treatment approaches rather than advocating for a specific therapy. He previews the program’s three sections: a data and landscape discussion of emerging clinical trials, a hot topics debate on patient selection, treatment duration, and sequencing, and a case-based discussion exploring real-world treatment decisions. Dr. Gradishar also explains his role as moderator and judge before the participating experts introduce themselves and their institutional affiliations.